[HTML][HTML] Transarterial radioembolization with yttrium-90 for the treatment of hepatocellular carcinoma

JR Kallini, A Gabr, R Salem, RJ Lewandowski - Advances in therapy, 2016 - Springer
Background Hepatocellular carcinoma (HCC) is a common cause of worldwide mortality.
Transarterial radioembolization (TARE) with yttrium-90 (Y90), a transcatheter intra-arterial …

Squamous cell carcinoma of the skin: epidemiology, classification, management, and novel trends

JR Kallini, N Hamed… - International journal of …, 2015 - Wiley Online Library
Squamous cell carcinoma ( SCC ) is the second most common non‐melanoma skin cancer.
It originates from epidermal keratinocytes or adnexal structures (such as eccrine glands or …

[PDF][PDF] Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000‐patient 15‐year experience

R Salem, A Gabr, A Riaz, R Mora, R Ali… - …, 2018 - Wiley Online Library
Yttrium‐90 transarterial radioembolization (TARE) is a locoregional therapy (LRT) for
hepatocellular carcinoma (HCC). In this study, we present overall survival (OS) outcomes in a 1,000…

Independent analysis of albumin-bilirubin grade in a 765-patient cohort treated with transarterial locoregional therapy for hepatocellular carcinoma

…, D Ganger, T Baker, M Abecassis, JR Kallini… - Journal of Vascular and …, 2016 - Elsevier
Purpose To assess validity of albumin-bilirubin (ALBI) grade as a predictor of survival in
patients undergoing transarterial embolization for hepatocellular carcinoma. Materials and …

90Y radioembolization for locally advanced hepatocellular carcinoma with portal vein thrombosis: long-term outcomes in a 185-patient cohort

…, R Ali, A Al Asadi, RA Mora, JR Kallini… - Journal of Nuclear …, 2018 - Soc Nuclear Med
We report survival outcomes for patients with advanced-stage hepatocellular carcinoma (HCC)
with portal vein thrombosis (PVT) treated with 90 Y radioembolization. Methods: With …

Same-day 90Y radioembolization: implementing a new treatment paradigm

A Gabr, JR Kallini, VL Gates, R Hickey, L Kulik… - European journal of …, 2016 - Springer
Purpose To assess the feasibility of conducting pretreatment mesenteric angiography, coil
embolization, 99m Tc macroaggregated albumin ( 99m Tc-MAA) scintigraphy, and 90 Y …

Comparison of the Adverse Event Profile of TheraSphere® with SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma: A Systematic Review

JR Kallini, A Gabr, K Thorlund, C Balijepalli… - Cardiovascular and …, 2017 - Springer
To compare the safety profiles of TheraSphere ® (glass) and SIR-Spheres ® (resin) Y90
microspheres for the treatment of hepatocellular carcinoma. A systematic review was conducted …

[PDF][PDF] Noncirrhotic complete obliterative portal vein thrombosis: Novel management using trans‐splenic transjugular intrahepatic portosystemic shunt with portal vein …

JR Kallini, A Gabr, L Kulik, D Ganger… - …, 2016 - Wiley Online Library
Discussion The incidence of noncirrhotic PVT is unclear, but is thought to account for 5%-10%
of patients with PH in developed countries. 3 For chronic noncirrhotic PVT, the American …

Tinea versicolor in dark‐skinned individuals

JR Kallini, F Riaz… - International journal of …, 2014 - Wiley Online Library
In this article, we review the salient features of tinea versicolor and describe the epidemiology,
clinical presentation, and histopathology of this mycosis in dark‐skinned individuals. …

Hepatic imaging following intra-arterial embolotherapy

JR Kallini, FH Miller, A Gabr, R Salem… - Abdominal …, 2016 - Springer
Purpose To discuss guidelines and salient imaging findings of solid tumors treated with
common intra-arterial procedures used in interventional oncology. Methods A meticulous …